Cargando…

Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group

BACKGROUND: The outcomes of unplanned surgery for bone sarcomas have not been frequently discussed. However, it is important to recognize patterns, treatment, and clinical outcomes of unplanned surgeries for patients with bone sarcomas. This multicenter study aimed to characterize the clinical outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Tomoki, Sugaya, Jun, Naka, Norifumi, Kobayashi, Hiroshi, Okuma, Tomotake, Kunisada, Toshiyuki, Asanuma, Kunihiro, Outani, Hedetatsu, Nishimura, Shunji, Kawashima, Hiroyuki, Akiyama, Toru, Yasuda, Taketoshi, Miwa, Shinji, Sudo, Akihiro, Ueda, Takafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567545/
https://www.ncbi.nlm.nih.gov/pubmed/33116858
http://dx.doi.org/10.2147/CMAR.S270178
_version_ 1783596346377240576
author Nakamura, Tomoki
Sugaya, Jun
Naka, Norifumi
Kobayashi, Hiroshi
Okuma, Tomotake
Kunisada, Toshiyuki
Asanuma, Kunihiro
Outani, Hedetatsu
Nishimura, Shunji
Kawashima, Hiroyuki
Akiyama, Toru
Yasuda, Taketoshi
Miwa, Shinji
Sudo, Akihiro
Ueda, Takafumi
author_facet Nakamura, Tomoki
Sugaya, Jun
Naka, Norifumi
Kobayashi, Hiroshi
Okuma, Tomotake
Kunisada, Toshiyuki
Asanuma, Kunihiro
Outani, Hedetatsu
Nishimura, Shunji
Kawashima, Hiroyuki
Akiyama, Toru
Yasuda, Taketoshi
Miwa, Shinji
Sudo, Akihiro
Ueda, Takafumi
author_sort Nakamura, Tomoki
collection PubMed
description BACKGROUND: The outcomes of unplanned surgery for bone sarcomas have not been frequently discussed. However, it is important to recognize patterns, treatment, and clinical outcomes of unplanned surgeries for patients with bone sarcomas. This multicenter study aimed to characterize the clinical outcomes of patients with bone sarcomas who underwent unplanned surgeries. PATIENTS AND METHODS: Data of 43 patients with bone sarcomas who underwent unplanned surgery between 2006 and 2017 were obtained from 23 hospitals in Japan. These included 18 cases of osteosarcoma, 9 of Ewing sarcoma, 8 of chondrosarcoma, and 6 of undifferentiated pleomorphic sarcoma. The study included 28 men and 15 women, with a mean age of 46 years. The mean follow-up duration was 59 months. RESULTS: The main primary tumor sites were the femur (n = 19), spine (n = 6), pelvis (n = 5), tibia (n = 3), and humerus (n = 3). The primary diagnoses were benign bone tumor (n = 24), trauma (n = 7), bone metastasis (n = 5), osteomyelitis (n = 4), degeneration (n=2), and unknown (n = 1). As unplanned surgeries, curettage, with or without bone graft, was performed in 26 patients; internal fixation was performed in 7; spinal surgery in 5; arthroplasty in 4; and arthroscopy in one. Thirty-eight patients received additional standard treatments. Thirty-four of these patients underwent surgical tumor resections, including amputation (n = 10), and the remaining 4 received radiotherapy or carbon ion radiotherapy as additional standard treatments. The 5-year disease-specific survival (DSS) rates in patients with osteosarcoma, Ewing sarcoma, and chondrosarcoma were 65.5%, 58.3%, and 72.9%, respectively. Twelve (27.9%) patients developed local recurrences (LR); among the total 43 patients studied, the 5-year DSS rates were significantly worse for those who developed LR compared to those who did not (p = 0.03). The 5-year DSS rates in patients with and without LR were 44% and 73.8%, respectively. CONCLUSION: We recommend that patients who have undergone unplanned surgery be administered standard treatment, including the option of amputation because herein, LR was shown to be a risk factor for decreased DSS.
format Online
Article
Text
id pubmed-7567545
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75675452020-10-27 Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group Nakamura, Tomoki Sugaya, Jun Naka, Norifumi Kobayashi, Hiroshi Okuma, Tomotake Kunisada, Toshiyuki Asanuma, Kunihiro Outani, Hedetatsu Nishimura, Shunji Kawashima, Hiroyuki Akiyama, Toru Yasuda, Taketoshi Miwa, Shinji Sudo, Akihiro Ueda, Takafumi Cancer Manag Res Original Research BACKGROUND: The outcomes of unplanned surgery for bone sarcomas have not been frequently discussed. However, it is important to recognize patterns, treatment, and clinical outcomes of unplanned surgeries for patients with bone sarcomas. This multicenter study aimed to characterize the clinical outcomes of patients with bone sarcomas who underwent unplanned surgeries. PATIENTS AND METHODS: Data of 43 patients with bone sarcomas who underwent unplanned surgery between 2006 and 2017 were obtained from 23 hospitals in Japan. These included 18 cases of osteosarcoma, 9 of Ewing sarcoma, 8 of chondrosarcoma, and 6 of undifferentiated pleomorphic sarcoma. The study included 28 men and 15 women, with a mean age of 46 years. The mean follow-up duration was 59 months. RESULTS: The main primary tumor sites were the femur (n = 19), spine (n = 6), pelvis (n = 5), tibia (n = 3), and humerus (n = 3). The primary diagnoses were benign bone tumor (n = 24), trauma (n = 7), bone metastasis (n = 5), osteomyelitis (n = 4), degeneration (n=2), and unknown (n = 1). As unplanned surgeries, curettage, with or without bone graft, was performed in 26 patients; internal fixation was performed in 7; spinal surgery in 5; arthroplasty in 4; and arthroscopy in one. Thirty-eight patients received additional standard treatments. Thirty-four of these patients underwent surgical tumor resections, including amputation (n = 10), and the remaining 4 received radiotherapy or carbon ion radiotherapy as additional standard treatments. The 5-year disease-specific survival (DSS) rates in patients with osteosarcoma, Ewing sarcoma, and chondrosarcoma were 65.5%, 58.3%, and 72.9%, respectively. Twelve (27.9%) patients developed local recurrences (LR); among the total 43 patients studied, the 5-year DSS rates were significantly worse for those who developed LR compared to those who did not (p = 0.03). The 5-year DSS rates in patients with and without LR were 44% and 73.8%, respectively. CONCLUSION: We recommend that patients who have undergone unplanned surgery be administered standard treatment, including the option of amputation because herein, LR was shown to be a risk factor for decreased DSS. Dove 2020-10-12 /pmc/articles/PMC7567545/ /pubmed/33116858 http://dx.doi.org/10.2147/CMAR.S270178 Text en © 2020 Nakamura et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Nakamura, Tomoki
Sugaya, Jun
Naka, Norifumi
Kobayashi, Hiroshi
Okuma, Tomotake
Kunisada, Toshiyuki
Asanuma, Kunihiro
Outani, Hedetatsu
Nishimura, Shunji
Kawashima, Hiroyuki
Akiyama, Toru
Yasuda, Taketoshi
Miwa, Shinji
Sudo, Akihiro
Ueda, Takafumi
Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group
title Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group
title_full Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group
title_fullStr Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group
title_full_unstemmed Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group
title_short Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group
title_sort standard treatment remains the recommended approach for patients with bone sarcoma who underwent unplanned surgery: report from the japanese musculoskeletal oncology group
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567545/
https://www.ncbi.nlm.nih.gov/pubmed/33116858
http://dx.doi.org/10.2147/CMAR.S270178
work_keys_str_mv AT nakamuratomoki standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup
AT sugayajun standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup
AT nakanorifumi standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup
AT kobayashihiroshi standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup
AT okumatomotake standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup
AT kunisadatoshiyuki standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup
AT asanumakunihiro standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup
AT outanihedetatsu standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup
AT nishimurashunji standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup
AT kawashimahiroyuki standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup
AT akiyamatoru standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup
AT yasudataketoshi standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup
AT miwashinji standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup
AT sudoakihiro standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup
AT uedatakafumi standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup